Latest Ebitda News

Page 14 of 320
Transmetro Corporation (ASX:TCO) delivered a 50% increase in FY2026 net profit to A$4.49 million, while cash rose to A$13.94 million and the fully franked dividend increased to 6 cents per share. The debt-free hotel operator is preparing to open Metro Hotel Martin Place Sydney and support a major refurbishment of its 220-room Marlow property.
Victor Sage
Victor Sage
29 Oct 2026
Xref reported A$4.7 million of unaudited Q1 FY2027 revenue and positive EBITDA of A$0.6 million, as its newer platform generated 48% revenue growth. Trust Marketplace checks, Pulse surveys and employee lifecycle products all recorded sharp increases, while stronger liquidity is supporting renewed marketing investment.
Victor Sage
Victor Sage
29 Oct 2026
AJ Lucas Group has started FY2027 with a sharp recovery from the previous quarter’s drilling disruption, although revenue and Australian EBITDA remain below last year’s levels. Negative operating cash flow, high borrowing costs and limited liquidity leave financing as the more consequential issue for investors.
Victor Sage
Victor Sage
29 Oct 2026
AVA Risk Group has opened FY27 with A$6.7 million in quarterly bookings and a 1.2 book-to-bill ratio, while acknowledging that FY26 revenue and profitability fell short of expectations. The company is betting that sharper commercial discipline, US expansion and a broader solutions model can turn a large pipeline into more dependable growth.
Victor Sage
Victor Sage
29 Oct 2026
Integral Diagnostics has opened FY27 below expectations, with radiologist and sonographer shortages limiting revenue growth and pushing labour costs ahead of sales. The company expects FY27 revenue growth of 4% to 6% and a full-year operating EBITDA margin of 19.5% to 20.5%, with improvement weighted to the second half.
Ada Torres
Ada Torres
29 Oct 2026
BSA Limited (ASX:BSA) suffered a steep first-quarter revenue decline after the nbn contract expired, with underlying EBITDA falling to a $0.6 million loss. The company is now relying on pipeline conversion and the proposed Eonetics acquisition to rebuild its earnings base.
Victor Sage
Victor Sage
29 Oct 2026
IGO delivered record Greenbushes spodumene production and a 49% jump in underlying EBITDA in the September quarter, while Nova approaches its final days of operation. The result strengthens the lithium portfolio’s earnings contribution, but Kwinana remains a substantial drag and Greenbushes’ next growth plan is not yet valued.
Maxwell Dee
Maxwell Dee
29 Oct 2026
8common remained EBITDA and operating-cashflow positive in the September quarter, even as revenue fell 7.8% year on year. Its $1.9 million Australian Taxation Office contract is yet to contribute revenue, with implementation expected to begin in January.
Victor Sage
Victor Sage
29 Oct 2026
Saluda Medical delivered a strong operational start to FY27, with US implants up 55% and quarterly revenue rising 26% to US$23.1 million. But the medical device company ended September with US$73.6 million in cash, US$100 million of secured debt drawn and estimated funding for just 2.3 quarters at the quarter’s cash-use rate.
Ada Torres
Ada Torres
29 Oct 2026
Appen has delivered its strongest quarterly result of FY26, with revenue rising 34% to US$73.9 million and underlying EBITDA increasing more than tenfold to US$10.3 million. Appen Global returned to profit while China continued to drive growth, although FY26 revenue is expected to land in the lower half of guidance.
Victor Sage
Victor Sage
29 Oct 2026
BetMakers delivered a step-change in Q1 FY27 profitability, with constant-currency revenue rising 16.3% and adjusted EBITDA climbing 176% to $5.9 million. Positive operating cash flow and stronger margins add weight to the company’s technology-led growth story, although the figures remain unaudited.
Sophie Babbage
Sophie Babbage
29 Oct 2026
Resolute Mining delivered 44,398 ounces of gold in the September quarter, while elevated costs and weaker shipments reduced EBITDA and net cash. Doropo construction and exploration advanced, but Syama’s recovery and the company’s full-year guidance now hinge on a stronger final quarter.
Maxwell Dee
Maxwell Dee
29 Oct 2026

Browse the archive

Full archive